{"id":62570,"date":"2026-01-30T16:06:01","date_gmt":"2026-01-30T15:06:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/"},"modified":"2026-01-30T16:06:01","modified_gmt":"2026-01-30T15:06:01","slug":"glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/","title":{"rendered":"GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&amp;D Pipeline Support Market Expansion &#8211; Forecast to 2030 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/6214979\/glp-1-analogues-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=f3b2xq&amp;utm_campaign=2144743+-+GLP-1+Analogues+Market+Research+2025%3A+Increasing+Diabetes+and+Obesity+Rates+and+a+Strong+R%26D+Pipeline+Support+Market+Expansion+-+Forecast+to+2030&amp;utm_exec=chdomspi\" rel=\"nofollow\" shape=\"rect\">&#8220;GLP-1 Analogues Market&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20260130773199\/en\/2706954\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260130773199\/en\/2706954\/22\/logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20260130773199\/en\/2706954\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260130773199\/en\/2706954\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report provides detailed information on glucagon-like peptide-1 (GLP-1) analogues. It analyzes market trends for GLP-1 analogues, with data from 2024, estimates from 2025, projections of compound annual growth rates (CAGRs) through 2030 (the forecast period 2025-2030) and regional markets for GLP-1 analogues.<\/p>\n<p>\nThis report highlights the current and future market potential of GLP-1 analogues and provides a detailed analysis of the competitive environment. It covers regulatory scenarios, drivers, restraints and opportunities, along with the market projections for 2030 and market share for key companies.<\/p>\n<p>\nThe GLP-1 analogue market is segmented by route of administration into oral and injection. By region, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.<\/p>\n<p>\nThe regional segment covers a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China and India. For market estimates, 2024 is used as the base year, with forecasts for 2025 and a projected value for 2030.<\/p>\n<p>\n<strong>The report includes:<\/strong><\/p>\n<ul>\n<li>\nAn overview of the current and future global markets for GLP-1 analogues<\/li>\n<li>\nIn-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030<\/li>\n<li>\nEstimates of the size and revenue prospects of the global market, along with a market share analysis by route of administration, indication and region<\/li>\n<li>\nFacts and figures pertaining to the market dynamics, technical advances, regulations and the impact of macroeconomic factors<\/li>\n<li>\nAn analysis of patents, emerging trends and developments in the industry<\/li>\n<li>\nAnalysis of the industry structure, including companies&#8217; market shares and rankings, strategic alliances, M&amp;A activity and a venture funding outlook<\/li>\n<li>\nOverview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies<\/li>\n<\/ul>\n<p>\n<strong>The report aims to:<\/strong><\/p>\n<ul>\n<li>\nAnalyze the market for GLP-1 analogues.<\/li>\n<li>\nAnalyze the global market size and market segments.<\/li>\n<li>\nUnderstand market constraints and drivers.<\/li>\n<li>\nProvide detailed market forecasts for 2030.<\/li>\n<li>\nAssess market share, competitiveness and industry structure.<\/li>\n<li>\nIdentify potential long-term impacts on the GLP-1 analogue market.<\/li>\n<\/ul>\n<p>\n<strong>Profiles of the Leading Companies<\/strong><\/p>\n<ul>\n<li>\nHansoh Pharmaceutical Group Co. Ltd.<\/li>\n<li>\nLilly USA LLC<\/li>\n<li>\nNovo Nordisk A\/S<\/li>\n<li>\nSanofi<\/li>\n<li>\nShanghai Benemae Pharmaceutical Corp.<\/li>\n<li>\nTeva Pharmaceutical Industries Ltd.<\/li>\n<\/ul>\n<p>\n<strong>Key Attributes:<\/strong><\/p>\n<table>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-left:solid black 1pt;\"><strong>Report Attribute<\/strong><\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;\"><strong>Details<\/strong><\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-left:solid black 1pt;\">No. of Pages<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;\">85<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-left:solid black 1pt;\">Forecast Period<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;\">2025 &#8211; 2030<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-left:solid black 1pt;\">Estimated Market Value (USD) in 2025<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;\">$54.8 Billion<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-left:solid black 1pt;\">Forecasted Market Value (USD) by 2030<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;\">$268.4 Billion<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-left:solid black 1pt;\">Compound Annual Growth Rate<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;\">30.6%<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border:solid black 1pt;\">Regions Covered<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-bottom:solid black 1pt;\">Global<\/p>\n<p>\n\u00a0<\/p>\n<p>\n\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\n<strong>Key Topics Covered:<\/strong><\/p>\n<p>\n<strong>Chapter 1 Executive Summary<\/strong><\/p>\n<ul>\n<li>\nMarket Outlook<\/li>\n<li>\nScope of Report<\/li>\n<li>\nMarket Summary<\/li>\n<li>\nMarket Dynamics and Growth Factors<\/li>\n<li>\nEmerging Technologies<\/li>\n<li>\nSegmental Analysis<\/li>\n<li>\nRegional Analysis<\/li>\n<li>\nConclusion<\/li>\n<\/ul>\n<p>\n<strong>Chapter 2 Market Overview<\/strong><\/p>\n<ul>\n<li>\nOverview<\/li>\n<li>\nAnalysis of Macroeconomic Factors<\/li>\n<li>\nImpact of U.S. Tariffs on the Pharmaceutical Industry<\/li>\n<li>\nHealthcare Expenditure<\/li>\n<li>\nMarket Demand and Demographics<\/li>\n<li>\nPorter&#8217;s Five Forces Analysis<\/li>\n<li>\nBargaining Power of Buyers (High)<\/li>\n<li>\nBargaining Power of Suppliers (Moderate to High)<\/li>\n<li>\nPotential for New Entrants (Low)<\/li>\n<li>\nThreat of Substitutes (Moderate)<\/li>\n<li>\nCompetitiveness in the Industry (High)<\/li>\n<\/ul>\n<p>\n<strong>Chapter 3 Market Dynamics<\/strong><\/p>\n<ul>\n<li>\nMarket Dynamics<\/li>\n<li>\nMarket Drivers<\/li>\n<li>\nIncreasing Cases of Diabetes and Obesity<\/li>\n<li>\nIncreasing Awareness of Diagnosis and Treatment Options for Diabetes<\/li>\n<li>\nStrong R&amp;D Pipeline<\/li>\n<li>\nMarket Restraints<\/li>\n<li>\nProduct Failure<\/li>\n<li>\nHigh Barriers for New Entrants<\/li>\n<li>\nMarket Opportunities<\/li>\n<li>\nExtended Therapeutic Uses<\/li>\n<li>\nIntegration in Telehealth and Weight Management Program<\/li>\n<\/ul>\n<p>\n<strong>Chapter 4 Regulatory Landscape<\/strong><\/p>\n<ul>\n<li>\nRegulatory Dynamics<\/li>\n<li>\nU.S.<\/li>\n<li>\nEurope<\/li>\n<li>\nJapan<\/li>\n<li>\nChina<\/li>\n<\/ul>\n<p>\n<strong>Chapter 5 Emerging Technologies and Pipeline Analysis<\/strong><\/p>\n<ul>\n<li>\nEmerging Trends\/Technologies<\/li>\n<li>\nNext-Generation Multi-Receptor Agonists<\/li>\n<li>\nInnovative Drug Delivery Methods<\/li>\n<li>\nExpanded Therapeutic Indications<\/li>\n<li>\nPipeline Analysis<\/li>\n<li>\nKey Takeaways<\/li>\n<li>\nPatent Analysis<\/li>\n<li>\nKey Takeaways<\/li>\n<\/ul>\n<p>\n<strong>Chapter 6 Market Segment Analysis<\/strong><\/p>\n<ul>\n<li>\nSegmentation Breakdown<\/li>\n<li>\nGlobal GLP-1 Analogues Market by Route of Administration<\/li>\n<li>\nKey Takeaways<\/li>\n<li>\nInjectable<\/li>\n<li>\nOral<\/li>\n<li>\nGeographic Breakdown<\/li>\n<li>\nGlobal GLP-1 Analogue Market by Region<\/li>\n<li>\nKey Takeaways<\/li>\n<li>\nNorth America<\/li>\n<li>\nEurope<\/li>\n<li>\nAsia-Pacific<\/li>\n<li>\nSouth America<\/li>\n<li>\nMiddle East and Africa<\/li>\n<\/ul>\n<p>\n<strong>Chapter 7 Competitive Intelligence<\/strong><\/p>\n<ul>\n<li>\nKey Takeaways<\/li>\n<li>\nCompetitive Landscape<\/li>\n<li>\nCompany Share Analysis<\/li>\n<\/ul>\n<p>\n<strong>Chapter 8 Sustainability in GLP-1 Analogues: ESG Perspective<\/strong><\/p>\n<ul>\n<li>\nIntroduction to ESG<\/li>\n<li>\nSustainability in the GLP-1 Analogue Market<\/li>\n<li>\nESG Perspective<\/li>\n<li>\nEnvironmental Impact<\/li>\n<li>\nSocial Impact<\/li>\n<li>\nGovernance Impact<\/li>\n<li>\nConclusion<\/li>\n<\/ul>\n<p>\n<strong>Chapter 9 Appendix<\/strong><\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/6214979\/glp-1-analogues-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=f3b2xq&amp;utm_campaign=2144743+-+GLP-1+Analogues+Market+Research+2025%3A+Increasing+Diabetes+and+Obesity+Rates+and+a+Strong+R%26D+Pipeline+Support+Market+Expansion+-+Forecast+to+2030&amp;utm_exec=chdomspi\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/af8b0n<\/a><\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong><\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"mail&#116;&#111;&#58;&#112;&#114;&#x65;&#x73;&#x73;&#x40;&#x72;&#x65;&#x73;earc&#104;&#97;&#110;&#100;&#109;&#x61;&#x72;&#x6b;&#x65;&#x74;&#x73;&#x2e;&#x63;om\" rel=\"nofollow\" shape=\"rect\">p&#114;&#x65;&#x73;&#x73;&#64;&#114;&#x65;&#x73;&#x65;a&#114;&#x63;&#x68;&#x61;n&#100;&#x6d;&#x61;&#x72;k&#101;&#x74;&#x73;&#x2e;c&#111;&#x6d;<\/a><\/p>\n<p>\nFor E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;GLP-1 Analogues Market&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides detailed information on glucagon-like peptide-1 (GLP-1) analogues. It analyzes market trends for GLP-1 analogues, with data from 2024, estimates from 2025, projections of compound annual growth rates (CAGRs) through 2030 (the forecast period 2025-2030) and regional markets for GLP-1 analogues. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62570","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&amp;D Pipeline Support Market Expansion - Forecast to 2030 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&amp;D Pipeline Support Market Expansion - Forecast to 2030 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;GLP-1 Analogues Market&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides detailed information on glucagon-like peptide-1 (GLP-1) analogues. It analyzes market trends for GLP-1 analogues, with data from 2024, estimates from 2025, projections of compound annual growth rates (CAGRs) through 2030 (the forecast period 2025-2030) and regional markets for GLP-1 analogues. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-30T15:06:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260130773199\/en\/2706954\/22\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&amp;D Pipeline Support Market Expansion &#8211; Forecast to 2030 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2026-01-30T15:06:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\\\/\"},\"wordCount\":776,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260130773199\\\/en\\\/2706954\\\/22\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\\\/\",\"name\":\"GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&amp;D Pipeline Support Market Expansion - Forecast to 2030 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260130773199\\\/en\\\/2706954\\\/22\\\/logo.jpg\",\"datePublished\":\"2026-01-30T15:06:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260130773199\\\/en\\\/2706954\\\/22\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260130773199\\\/en\\\/2706954\\\/22\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&amp;D Pipeline Support Market Expansion &#8211; Forecast to 2030 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&amp;D Pipeline Support Market Expansion - Forecast to 2030 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&amp;D Pipeline Support Market Expansion - Forecast to 2030 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;GLP-1 Analogues Market&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides detailed information on glucagon-like peptide-1 (GLP-1) analogues. It analyzes market trends for GLP-1 analogues, with data from 2024, estimates from 2025, projections of compound annual growth rates (CAGRs) through 2030 (the forecast period 2025-2030) and regional markets for GLP-1 analogues. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2026-01-30T15:06:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260130773199\/en\/2706954\/22\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&amp;D Pipeline Support Market Expansion &#8211; Forecast to 2030 &#8211; ResearchAndMarkets.com","datePublished":"2026-01-30T15:06:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/"},"wordCount":776,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260130773199\/en\/2706954\/22\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/","name":"GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&amp;D Pipeline Support Market Expansion - Forecast to 2030 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260130773199\/en\/2706954\/22\/logo.jpg","datePublished":"2026-01-30T15:06:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260130773199\/en\/2706954\/22\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260130773199\/en\/2706954\/22\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/glp-1-analogues-market-research-2025-increasing-diabetes-and-obesity-rates-and-a-strong-rd-pipeline-support-market-expansion-forecast-to-2030-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&amp;D Pipeline Support Market Expansion &#8211; Forecast to 2030 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62570"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62570\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}